Two Drugs Bring New Hope for Pancreatic Cancer Treatment
One of the drugs, currently in phase II trials, targets specific genetic mutations found in a subset of pancreatic tumors. Initial data presented at the American Society of Clinical Oncology conference in June 2023 revealed that patients receiving this targeted therapy experienced a significant reduction in tumor size, leading to hopes for more personalized treatment … Read more